All In Biotech

Drug Trial Radar · NCT05691244

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

A Multicentric, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke.

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 514 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

514

Planned (sponsor's estimate)

Start

Jul 24, 2025

Primary completion

Sep 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Pharmazz, Inc.Industry
Sponsor type
Industry
First posted
Jan 19, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and agents that can be used for neurorepair in later stages of stroke. Several trials have been conducted and are in progress using different pharmacological agents, but none of the studies involve the stimulation of ETB receptors to treat cerebral ischemic stroke. Sovateltide (IRL-1620, PMZ-1620) has been effective in animal models of cerebral ischemic stroke. Its safety and tolerability have been demonstrated in a human phase I study with 7 subjects. Clinical phase II and III results indicate that sovateltide is a novel, first-in-class, highly effective drug candidate for treating cerebral ischemic stroke. Safety and significant efficacy in improving the National Institutes of Health Stroke Scale (NIHSS), Modified Rankin scale (mRS), and Barthel index (BI) obtained in phase II and III studies in patients with cerebral ischemic stroke in India are convincing and encouraged us to investigate its safety and efficacy in cerebral ischemic stroke patients in the United States. Therefore, the plan is to conduct a phase III clinical study to evaluate the safety and efficacy of sovateltide therapy along with standard of care in patients of acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke
  • Cerebral Stroke

Interventions

  • Drug: Normal SalineDrug

    Normal saline to be used as vehicle in the phase-III study to assess efficacy of sovateltide in patients with acute cerebral ischemic stroke.

  • SovateltideDrug

    Phase-III study to assess efficacy of sovateltide in patients with acute cerebral ischemic stroke.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine the efficacy of sovateltide in patients with acute cerebral ischemic stroke assessed by modified Rankin Scale (mRS) score of 0-2 at day 90 post-randomization.Time frame: Day 1 through Day 90

Locations

57 sites in 5 countries. Site status is shown where the registry gives one.

  • The University of Arizona - College of Medicine

    Tucson, Arizona · Recruiting

  • Mercy Medical Group

    Carmichael, California · Recruiting

  • St. John's Regional Medical Center

    Oxnard, California · Recruiting

  • Sarasota Memorial Hospital

    Sarasota, Florida · Recruiting

  • Wellstar Kennestone Hospital

    Marietta, Georgia · Recruiting

  • SSM Health Neurosciences

    Bridgeton, Missouri · Recruiting

  • Hackensack University Medical Center at Paramus

    Paramus, New Jersey · Recruiting

  • UNC Medical Center

    Chapel Hill, North Carolina · Recruiting

  • Guilford Neurologic Associates Inc

    Greensboro, North Carolina · Recruiting

  • OSU Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Penn State Health Milton S. Hershey Medical Center

    Hershey, Pennsylvania · Recruiting

  • UPMC Presbyterian Hospital

    Pittsburgh, Pennsylvania · Recruiting

  • CHI Memorial Neuroscience Institute

    Chattanooga, Tennessee · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Recruiting

  • Houston Medical Neurological Institute

    Houston, Texas · Recruiting

  • Memorial Hermann Hospital

    Houston, Texas · Recruiting

  • Liverpool Hospital

    Liverpool, New South Wales, Australia · Recruiting

  • RHON-KLINIKUM Campus Bad Neustadt

    Bad Neustadt an der Saale, Germany · Recruiting

  • Universitaetsklinikum Erlangen

    Erlangen, Germany · Recruiting

  • Universitätsklinikum Essen AöR

    Essen, Germany · Recruiting

  • Universitätsklinikum Schleswig-Holstein AöR

    Lübeck, Germany · Recruiting

  • University Hospital Tuebingen

    Tübingen, Germany · Recruiting

  • Klinikum Altenburger Land GmbH

    Altenburg, Altenburg, Germany · Recruiting

  • Universitaetsklinikum Goettingen

    Göttingen, Lower Saxony, Germany · Recruiting

  • Klinikum der Stadt Ludwigshafen gGmbh

    Rhein, Ludwigshafen Am, Germany · Recruiting

  • Muhlenkreiskliniken (MKK) - Johannes Wesling Klinikum Minden - Neurologische Klinik

    Minden, North Rhine-Westphalia, Germany · Recruiting

  • Klinik fuer Neurologie, Stroke Unit und Fruehrehabilitation Dorstener Strae 151

    Recklinghausen, Recklinghausen, Germany · Recruiting

  • Charite-Universitaetsmedizin Berlin

    Berlin, State of Berlin, Germany · Recruiting

  • Instituto de Investigación Biomédica de A Coruña

    A Coruña, Spain · Recruiting

  • Hospital Universitario Infanta Cristina (HUB)

    Badajoz, Spain · Recruiting

  • Hospital Universitario de Cruces

    Barakaldo, Spain · Recruiting

  • Institut Catala d'Oncologia (ICO) - Hospital Universitari Doctor Josep Trueta

    Girona, Spain · Recruiting

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain · Recruiting

  • Hospital Clinico San Carlos

    Madrid, Spain · Recruiting

  • Medical Imbrain S.L.

    Melilla, Spain · Recruiting

  • Hospital Clinico Universitario de Santiago

    Santiago, Spain · Recruiting

  • Hospital Universitario Virgen del Rocio

    Seville, Spain · Recruiting

  • Hospital Clinico Universitario de Valencia

    Valencia, Spain · Recruiting

  • Hospital Universitari i Politecnic La Fe de Valencia

    Valencia, Spain · Recruiting

  • Hospital Universitario Miguel Servet

    Zaragoza, Spain · Recruiting

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.